首页> 外文OA文献 >Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study

【2h】

Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study

机译：逐渐逐渐逐渐逐渐逐渐逐渐变细，在类风湿性关节炎患者达到受控病后常规合成DMARts：随机对照塔拉研究的一年结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Elise van Mulligen; Pascal Hendrik Pieter de Jong; Tjallingius Martijn Kuijper; Myrthe van der Ven; Cathelijne Appels; Casper Bijkerk; Joop B Harbers; Yael de Man; T H Esmeralda Molenaar; Ilja Tchetverikov; Yvonne P M Goekoop-Ruiterman; Jende van Zeben; Johanna M W Hazes; Angelique E A M Weel; Jolanda J Luime;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study [J] . van Mulligen Elise, de Jong Pascal Hendrik Pieter, Kuijper Tjallingius Martijn, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2019,第6期

机译：在类风湿性关节炎患者达到受控疾病后逐渐逐渐逐渐逐渐逐渐逐渐逐渐逐渐变细。随机控制塔拉研究的一年结果
2. Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial [J] . Takeuchi Tsutomu, Tanaka Yoshiya, Soen Satoshi, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2019,第7期

机译：抗rankl抗体Denosumab对常规综合性疾病修饰抗腹炎治疗类风湿性关节炎患者联合结构损伤的影响（理想的研究）：随机，双盲，安慰剂控制第3期试验
3. The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug [J] . Nuria Navarro Coy, Sarah Brown, Ailsa Bosworth, BMC Musculoskeletal Disorders . 2014,第1期

机译：“ Switch”研究方案：在风湿性关节炎患者中，最初的TNF抑制剂药物治疗失败后，转换为肿瘤坏死因子（TNF）抑制剂药物或abatacept或利妥昔单抗的随机对照试验
4. Early disease control by low-dose prednisone comedication may affect the quality of remission In patients with early rheumatoid arthritis [C] . Monica Todoerti, Carlo Alberto Scire, Nicola Boffini, International Conference on the Neuroendocrine Immune Basis of the Rheumatic Diseases . 2010

机译：低剂量泼尼松的早期疾病控制可能会影响早期类风湿性关节炎患者的缓解质量
5. Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised double-blind placebo-controlled phase 3 trial [O] . Tsutomu Takeuchi, Yoshiya Tanaka, Satoshi Soen, -1

机译：抗RANKL抗体denosumab对类风湿关节炎患者使用传统的合成疾病缓解性抗风湿药治疗的关节结构损伤的影响（DESIRABLE研究）：一项随机双盲安慰剂对照的3期试验
6. OP0113 Gradual tapering tnf blockers versus conventional synthetic dmards in patients with rheumatoid arthritis in sustained remission: first year results of the randomised controlled tara-study [O] . E. Van Mulligen, A. E. A. M. Weel, T.M. Kuijper, 2018

机译：OP0113逐渐逐渐逐渐逐渐逐渐变细胞阻断者与类风湿性关节炎持续缓解患者的常规合成DMARD：随机控制的第一年结果 - 研究

Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study

著录项

引文网络

相似文献

相关主题

期刊订阅